1,3,7-triazaspiro[4.4]nonane-2,4-dione hydrochloride, 95%, 1g

1-(2-Amino-3,5-dibromophenyl)ethanone, 95.0%, 1g

2-Phenylpyrimidine-4-carboxylic acid, 95.0%, 2.5g

2-AMINO-2-PHENYLPROPAN-1-OL HYDROCHLORIDE, 95.0%, 250mg

(6bR,10aS)-3-Methyl-2,3,6b,7,8,9,10,10a-octahydro-1H-pyrido[3',4':4,5]pyrrolo[1,2,3-de]quinoxaline, 97.0%, 1g

5-Ethynyl-1,2,3-trifluorobenzene>98.0%(GC)1g

2-Methyl-1-hexene, 97.0%, 5g

Solución estándar Silver ICP, 100 ml, 1 000 mg/L Ag, HDPE

(1-imidazo[2,1-b][1,3,4]thiadiazol-6-ylethyl)amine dihydrochloride, 95.0%, 250mg

(R)-2-((tert-Butoxycarbonyl)amino)-3-(4-(trifluoromethyl)phenyl)propanoic acid, 95.0%, 10g

7-Bromobenzo[c][1,2,5]thiadiazole-4-carbaldehyde, 97.0%, 10g

2-METHYLPYRAZOLO[1,5-A][1,3,5]TRIAZIN-4(1H)-ONE, 95.0%, 500mg

Trimethyl 1,3,5-Benzenetricarboxylate>98.0%(GC)25g